Immunovant, Inc.
IMVTNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $5.84B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $18.51$45.42
- Volume (live)
- -
- Avg. volume (3M)
- 1.57M
Immunovant (IMVT) Stock Price & Financial Analysis
Immunovant Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $28.14 - $28.93 |
|---|---|
| 52-Week High | $45.42 |
| 52-Week Low | $18.51 |
| Open | $28.93 |
| Volume (last close) | 641.35K |
| Average Volume (3M) | 1.57M |
| Revenue (TTM) | 7.09M |
|---|---|
| Net Income (TTM) | -538.22M |
| Free Cash Flow (TTM) | -414.31M |
| EPS (TTM) | −$2.82 |
| Profit Margin | -7585.86% |
| Operating Margin | -7877.46% |
| Return on Equity (ROE) | -73.19% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 5.84B |
|---|---|
| Shares Outstanding | 205.55M |
| Price to Sales (P/S) | 823.05 |
| Price to Book (P/B) | 7.94 |
| EV/EBITDA | -9.50 |
| 50-Day MA | $36.82 |
|---|---|
| 200-Day MA | $31.93 |
| 1-Year Change | +55.28% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Immunovant at a Glance
As of the Oct 23, 2026 close, Immunovant (IMVT) has a market capitalization of $5.84B. The stock trades at 823.0× sales. Over the trailing twelve months it lost $538.22M on revenue of $7.09M and burned $414.31M of free cash flow.
As of its latest reported balance sheet, it holds $797.80M in cash and securities against $0.00 of debt, a net cash position of $797.80M.
Immunovant does not currently pay a dividend.
The share price is up 55.3% over the past year. At $28.41 (the Oct 23, 2026 close) it sits within its 52-week range of $18.51 to $45.42, below its 200-day moving average of $31.93.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $48.80, 71.8% above the Oct 23, 2026 close.
Frequently Asked Questions About Immunovant
What is the current stock price for IMVT?
As of the Oct 23, 2026 close, IMVT stock trades at $28.41. The 52-week range is $18.51–$45.42, with a day range of $28.14–$28.93.
What is the P/E ratio for IMVT?
The P/E ratio (Price-to-Earnings) for IMVT is shown in the Key Statistics section. This valuation metric helps compare Immunovant, Inc. to industry peers.
Does IMVT pay dividends?
Immunovant does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IMVT?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for IMVT is Buy. The average 12-month price target is $48.80, a 71.8% upside from the Oct 23, 2026 close of $28.41.
What is the market cap of IMVT?
As of the Oct 23, 2026 close, Immunovant's market capitalization is $5.84B, classifying it as a mid-cap company. Immunovant operates in the Healthcare sector within the Biotechnology industry.